IPRIPR2023-01069Terminated-Settled
Samsung Bioepis Co., Ltd.v.Alexion Pharmaceuticals, Inc. et al.
IPR challenge of US 10590189.
Type
IPR
Filed
Jun 16, 2023
Instituted
Dec 20, 2023
Decided
Sep 4, 2024
Patent
Application
15642096
Inventor
Leonard BELL et al
Granted
Mar 17, 2020
01
Timeline
3 milestones
2023-06-16Petition filed
2023-12-20Institution
2024-09-04Terminated
02
Parties & counsel
Petitioner
Samsung Bioepis Co., Ltd.
Counsel
Rhyu, Michelleet al
Patent Owner
Alexion Pharmaceuticals, Inc. et al.
Counsel
Flattmann, Geraldet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →